The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study of endogenous T cell therapy using SLC45A2-specific CD8 T cells for patients with metastatic uveal melanoma.
 
Suzanne Phillips
No Relationships to Disclose
 
Shailbala Singh
No Relationships to Disclose
 
Gregory Lizee
Patents, Royalties, Other Intellectual Property - University of Texas Health Science
 
Luisa Maren Solis
No Relationships to Disclose
 
James William Welsh
Employment - MD Anderson Cancer Center; MD Anderson Cancer Center
Leadership - MolecularMatch; MolecularMatch
Stock and Other Ownership Interests - Alpine Immune Sciences; Checkmate Pharmaceuticals; Legion Healthcare Partners; Mavupharma; MolecularMatch; Nanobiotix; Nanorobotix; Oncoresponse; Reflexion Medical; Reflexion Medical; Reflexion Medical
Honoraria - Aileron Therapeutics; Alpine Immune Sciences; American Association of Physicists in Medicine; Nanobiotix; Reflexion Medical; Roche; Shandong Cancer Hospital; The Korean Society for Radiation Oncology; Varian Medical Systems
Consulting or Advisory Role - Aileron Therapeutics; Alpine Immune Sciences; AstraZeneca; Checkmate Pharmaceuticals; Genentech; Legion Healthcare Partners; Mavu Pharmaceutical; Merck; MolecularMatch; Nanobiotix; Nanorobotix; Oncorena; Oncoresponse; Reflexion Medical; Ventana Medical Systems
Research Funding - Aileron Therapeutics; Alkermes; Artidis; Bristol-Myers Squibb; Checkmate Pharmaceuticals; Checkmate Pharmaceuticals; Hotspot Therapeutics; Mavu Pharmaceutical; Merck; Nanobiotix; Reflexion Medical; Takeda
Patents, Royalties, Other Intellectual Property - MolecularMatch; MP470 (amuvatinib); MRX34 regulation of PDL1; XRT technique to overcome immune resistance
Travel, Accommodations, Expenses - AACR; Aileron Therapeutics; American Society for Radiation Oncology; Gustave Roussy Cancer Center; IASLC; MedAustron; Nanobiotix; Radiation Research Society; Reflexion Medical; Shandong Cancer Hospital; The Korean Society for Radiation Oncology; The Korean Society for Radiation Oncology; The Korean Society for Radiation Oncology; Turkish Society of Lung Cancer
 
Roland L. Bassett
No Relationships to Disclose
 
Lisa G Beal
No Relationships to Disclose
 
Peter Y. Kim
No Relationships to Disclose
 
Ravi Murthy
No Relationships to Disclose
 
Amjad Talukder
Patents, Royalties, Other Intellectual Property - Zelluna Therapeutics
 
Ivy Lai
No Relationships to Disclose
 
Cassian Yee
Stock and Other Ownership Interests - Berkeley Lights; immatics; NextNet; Obsidian Therapeutics; Rootpath; Scribe; T-Cypher Bio
Consulting or Advisory Role - Achelois Oncology; Achelois Oncology; Achilles Therapeutics; Immatics; NextNet; Obsidian Therapeutics; Rootpath; T-Cypher Bio
Patents, Royalties, Other Intellectual Property - Invention for discovery of tumor antigen targets and TCR sequences
 
Sapna Pradyuman Patel
Honoraria - Delcath Systems; Emory University
Consulting or Advisory Role - Bristol Myers Squibb; Castle Biosciences; Delcath Systems; immatics; Immunocore; Novartis; Pfizer; Replimune; TriSalus Life Sciences
Research Funding - Bristol-Myers Squibb (Inst); Foghorn Therapeutics (Inst); InxMed (Inst); Lyvgen Biopharma (Inst); Novartis (Inst); Provectus (Inst); Seagen (Inst); Syntrix Biosystems (Inst); TriSalus Life Sciences (Inst)
Travel, Accommodations, Expenses - InxMed; TriSalus Life Sciences